| LATEST NEWS | Cost implications from raw materials and other costs visible after June -- Energy Commission | The Energy Commission is looking at energy cost scenarios in case the West Asia conflict is prolonged — CEO | The Energy Commission has done its part to secure raw supply for energy fuel in short term period - EC CEO | About 85 pct of domestic or household consumers will remain at a stable or neutral level in terms of electricity bill impact following the incentive -- Energy Commission CEO | Automatic Fuel Adjustment: Electricity, gas tariff adjustments to be made periodically based on the actual cost of supply - Energy Commission CEO | |
KUALA LUMPUR, Oct 17 (Bernama) -- A total investment of RM85.7 billion in research and development (R&D) is required to achieve the targets set by the National Science, Technology and Innovation Policy (NSTIP) 2021-2030, according to the Ministry of Science, Technology, and Innovation (MOSTI).
KUALA LUMPUR, Oct 15 (Bernama) -- Malaysian innovators and manufacturers should seize the opportunity to tap into the immense potential of the global medical devices industry, which is projected to reach nearly US$800 billion by 2030, says Science, Technology and Innovation (MOSTI) Minister Chang Lih Kang.
KUALA LUMPUR, Oct 12 (Bernama) -- Malaysia and Turkiye are exploring potential collaboration in the field of green and alternative energy, in line with Malaysia’s commitment to adopting more sustainable and eco-friendly energy sources.
KUALA LUMPUR, Oct 11 (Bernama) -- The just-concluded three-day Enlit Asia 2024 has called on ASEAN to unite, embrace digitalisation and drive innovation to accelerate the region’s energy transition agenda.
SERDANG, Oct 3 (Bernama) -- The Ministry of Science, Technology and Innovation (MOSTI) is proposing an increase in allocation for research and development (R&D) under Budget 2025, said its minister Chang Lih Kang.
By Durratul Ain Ahmad Fuad
KUALA LUMPUR, Sept 15 (Bernama) – Integrated biotech group ALPS Global Holding Bhd, which is en route to a Nasdaq listing in the fourth quarter of 2024, aims to raise US$100 million to fund its expansion, clinical studies, and manufacturing plant.
